Cancer Patients Willing to Undergo Pre-Trial Testing

Article

HealthDay News - Greater willingness to undergo pharmacodynamic, pharmacokinetic tests found with fewer tests

HealthDay News - Patients with advanced malignancies appear to be quite willing to undergo pharmacodynamic (PD) and pharmacokinetic (PK) tests in order to be enrolled in clinical trials, according to research published online Jan. 18 in Cancer.

Raoul Tibes, MD, PhD, of the Mayo Clinic in Scottsdale, Ariz., and colleagues prospectively measured the willingness of 61 patients with advanced malignancies to undergo various procedures and imaging tests, and how many tests patients would tolerate.

The researchers found that, overall, patients' willingness to undergo study-required tests was quite high, more so for blood and urine tests, ultrasounds, X-rays, echocardiograms, and computed tomography than for tumor and skin biopsies and magnetic resonance imaging. There was an inverse relationship between willingness to undergo tests and the frequency of the tests. Willingness was modestly influenced by inconvenience and prior bad experiences with invasive testing, and positively correlated with college education, insurance coverage, and requirement of the tests for enrollment.

"The current findings provide the first prospectively collected data on patients' willingness to undergo PK/PD tests and imaging studies associated with early stage oncology drug trials and can serve as basis for further exploration toward the design of patient-friendly, biomarker-driven clinical studies in oncology," the authors write.

AbstractFull Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.